FFA
VRTX icon

Farther Finance Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Farther Finance Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Buy
4,922
+170
+4% +$75.3K 0.02% 654
2026
Q1 		$2.13M Buy
4,752
+331
+7% +$154K 0.02% 620
2025
Q4 		$2M Buy
4,421
+1,028
+30% +$443K 0.02% 577
2025
Q3 		$1.33M Buy
3,393
+487
+17% +$204K 0.02% 598
2025
Q2 		$1.29M Buy
2,906
+35
+1% +$16.1K 0.03% 498
2025
Q1 		$1.39M Buy
2,871
+462
+19% +$215K 0.04% 391
2024
Q4 		$970K Buy
2,409
+107
+5% +$49.6K 0.04% 378
2024
Q3 		$1.07M Sell
2,302
-10
-0.4% -$4.8K 0.04% 332
2024
Q2 		$1.09M Buy
2,312
+1,476
+177% +$641K 0.05% 286
2024
Q1 		$352K Buy
836
+108
+15% +$45.7K 0.02% 484
2023
Q4 		$296K Buy
728
+515
+242% +$190K 0.02% 447
2023
Q3 		$74.1K Buy
213
+68
+47% +$23.8K 0.01% 656
2023
Q2 		$51K Buy
145
+8
+6% +$2.69K 0.01% 667
2023
Q1 		$43.2K Sell
137
-37
-21% -$11.1K 0.01% 641
2022
Q4 		$50.2K Buy
+174
New +$53K 0.02% 484

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Farther Finance Advisors's VRTX Position: Q2 2026 in Review

Farther Finance Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 3.6% in Q2 2026, buying an estimated $75.3K and bringing the position to 4,922 shares worth $2.45M. The position accounts for 0.02% of the portfolio, ranked #654.

Farther Finance Advisors first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Farther Finance Advisors held 4,922 shares of Vertex Pharmaceuticals worth $2.45M as of Q2 2026.
  • Farther Finance Advisors bought 170 Vertex Pharmaceuticals shares in Q2 2026, an estimated $75.3K.
  • Vertex Pharmaceuticals made up 0.02% of Farther Finance Advisors's portfolio in Q2 2026, its #654 holding.
  • Farther Finance Advisors first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.